Lalima Sharma

Title: Lalima Sharma: Innovator in Protein Kinase Inhibitors

Introduction

Lalima Sharma is a distinguished inventor based in Chandigarh, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds as protein kinase inhibitors. With a total of two patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Lalima Sharma's latest patents focus on heterocyclic compounds that serve as protein kinase inhibitors. The present invention provides a heterocyclic compound of formula (I), along with its pharmaceutically acceptable salts, prodrugs, or hydrates. This invention includes a pharmaceutical composition comprising the compound as an active ingredient, along with methods of production and use. Specifically, these compounds are useful for treating or preventing diseases associated with protein kinases, particularly those related to the Janus Kinase family.

Career Highlights

Lalima Sharma is currently employed at Daiichi Sankyo Company, Limited, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in the development of new compounds has positioned her as a valuable asset in her field.

Collaborations

Some of her notable coworkers include Ashwani Kumar Verma and Kumaragurubaran Nagaswamy, who collaborate with her on various projects within the company.

Conclusion

Lalima Sharma's work in the development of protein kinase inhibitors showcases her dedication to advancing medical science. Her contributions are significant in the ongoing quest for effective treatments for various diseases.